SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Timo K. Nykopp, Sanna Pasonen-Seppänen, Markku I. Tammi, Raija H. Tammi, Veli-Matti Kosma, Maarit Anttila, Reijo Sironen, Decreased hyaluronidase 1 expression is associated with early disease recurrence in human endometrial cancer, Gynecologic Oncology, 2015, 137, 1, 152

    CrossRef

  2. 2
    T. J. Yates, L. E. Lopez, S. D. Lokeshwar, N. Ortiz, G. Kallifatidis, A. Jordan, K. Hoye, N. Altman, V. B. Lokeshwar, Dietary Supplement 4-Methylumbelliferone: An Effective Chemopreventive and Therapeutic Agent for Prostate Cancer, JNCI Journal of the National Cancer Institute, 2015, 107, 7, djv085

    CrossRef

  3. 3
    Xintao Li, Xin Ma, Luyao Chen, Liangyou Gu, Yu Zhang, Fan Zhang, Yun Ouyang, Yu Gao, Qingbo Huang, Xu Zhang, Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis, Scientific Reports, 2015, 5, 13157

    CrossRef

  4. 4
    F. Augustin, M. Fiegl, T. Schmid, G. Pomme, W. Sterlacci, A. Tzankov, Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer, Journal of Clinical Pathology, 2015, 68, 5, 368

    CrossRef

  5. 5
    Päivi Auvinen, Kirsi Rilla, Ritva Tumelius, Markku Tammi, Reijo Sironen, Ylermi Soini, Veli-Matti Kosma, Arto Mannermaa, Jukka Viikari, Raija Tammi, Hyaluronan synthases (HAS1–3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival, Breast Cancer Research and Treatment, 2014, 143, 2, 277

    CrossRef

  6. 6
    Michael Garcia-Roig, Nicolas Ortiz, Vinata Lokeshwar, Molecular Marker for Predicting Treatment Response in Advanced Renal Cell Carcinoma: Does the Promise Fulfill Clinical Need?, Current Urology Reports, 2014, 15, 1

    CrossRef

  7. 7
    Hideo Shigeishi, Koichiro Higashikawa, Masaaki Takechi, Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers, Journal of Cancer Research and Clinical Oncology, 2014, 140, 10, 1629

    CrossRef

  8. 8
    Vinata B. Lokeshwar, Summan Mirza, Andre Jordan, Hyaluronan Signaling and Turnover, 2014,

    CrossRef

  9. 9
    Caitlin O. McAtee, Joseph J. Barycki, Melanie A. Simpson, Hyaluronan Signaling and Turnover, 2014,

    CrossRef

  10. 10
    Anaid Benitez, Travis J. Yates, N. Shamaldevi, Tim Bowen, Vinata B. Lokeshwar, Dietary Supplement Hymecromone and Sorafenib: A Novel Combination for the Control of Renal Cell Carcinoma, The Journal of Urology, 2013, 190, 1, 285

    CrossRef

  11. 11
    Xiaojie Tan, Songqin He, Yifang Han, Yongwei Yu, Jianru Xiao, Danfeng Xu, Guoping Wang, Yan Du, Wenjun Chang, Jianhua Yin, Tong Su, Jianguo Hou, Guangwen Cao, Establishment and characterization of clear cell renal cell carcinoma cell lines with different metastatic potential from Chinese patients, Cancer Cell International, 2013, 13, 1, 20

    CrossRef

  12. 12
    Michał S. Karbownik, Jerzy Z. Nowak, Hyaluronan: Towards novel anti-cancer therapeutics, Pharmacological Reports, 2013, 65, 5, 1056

    CrossRef

  13. 13
    Jeffrey C. Gahan, Miguel Gosalbez, Travis Yates, Ezekiel E. Young, Diogo O. Escudero, Andrew Chi, Michael Garcia-Roig, Ramgopal Satyanarayana, Mark S. Soloway, Vincent G. Bird, Vinata B. Lokeshwar, Chemokine and Chemokine Receptor Expression in Kidney Tumors: Molecular Profiling of Histological Subtypes and Association With Metastasis, The Journal of Urology, 2012, 187, 3, 827

    CrossRef